Bexion begins Phase I trial of BXQ-350 to treat advanced solid tumours

US-based biotech company Bexion Pharmaceuticals has begun its Phase I trial of BXQ-350 to treat advanced solid tumours.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news